| Open Document File Size: 162,16 KBShare Result on Facebook
Company N England Journal / SMC No. (755/12) Bayer PLC / British Pharmaceutical Industry / / Country United Kingdom / Scotland / / Currency GBP / INR / / Facility National Institute / / IndustryTerm comparator products / above product / health technology appraisal / / MedicalCondition recurrent deep vein thrombosis / pain / epistaxis / deep vein thrombosis / proximal limb deep vein thrombosis / headache / venous thromboembolism / nasopharyngitis / pulmonary embolism / symptomatic pulmonary embolism / symptomatic venous thromboembolism / thromboembolism / proximal deep vein thrombosis / / MedicalTreatment hip and knee surgery / invasive procedure / surgery / / Organization National Institute for Health and Clinical Excellence / NHS / Association of the British Pharmaceutical Industry / / Position physician / Major / Chairman / / Product vitamin K / / ProvinceOrState Prince Edward Island / / URL http /
SocialTag |
rivaroxaban 15 and 20mg film-coated tablets (Xarelto®) SMC No[removed]Bayer PLC 13 January 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area